`a(CHEBI:rhodanine) decreases p(HBP:"Tau aggregates")`

Other possible inhibitors of tau aggregation are rhodanine-based inhibitors, phenylthiazolyl-hydrazide inhibitors, N-phenylamines, phenothiazines and benzothiazoles, and polyphenols and anthraquinones

- a(CHEBI:Iproniazid) decreases p(HBP:"Tau aggregates")
- a(CHEBI:daunorubicin) decreases p(HBP:"Tau aggregates")
- a(CHEBI:doxorubicin) decreases p(HBP:"Tau aggregates")
- a(CHEBI:emodin) decreases p(HBP:"Tau aggregates")
- a(CHEBI:iproclozide) decreases p(HBP:"Tau aggregates")
- a(CHEBI:isoniazide) decreases p(HBP:"Tau aggregates")
- a(CHEBI:myricetin) decreases p(HBP:"Tau aggregates")
- a(CHEBI:quinalizarin) decreases p(HBP:"Tau aggregates")
- a(CHEBI:thiostrepton) decreases p(HBP:"Tau aggregates")
- a(HBP:isocarboxazide) decreases p(HBP:"Tau aggregates")
- a(HBP:oxazolidinedione) decreases p(HBP:"Tau aggregates")
- a(HBP:sudoxicam) decreases p(HBP:"Tau aggregates")
- a(HBP:thiohydantoin) decreases p(HBP:"Tau aggregates")
- a(HBP:thioxooxazolidine) decreases p(HBP:"Tau aggregates")

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., &
Hofmann-Apitius, M. (2018). BEL Commons: an environment for
exploration and analysis of networks encoded in Biological Expression Language. *Database*, 2018(3), 1–11.